EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)
$7.02 -0.18 (-2.5%)
Analysed EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) News Sources
Eupraxia Reports Latest 36-Week Results From Resolve Trial
21-04-2026
yahoo.com
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
21-04-2026
yahoo.com
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
13-04-2026
yahoo.com
New Strong Sell Stocks for April 2nd
02-04-2026
yahoo.com
Eupraxia Reports Positive Six-Month Data From Eosinophilic Esophagitis Trial
17-03-2026
yahoo.com
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
17-03-2026
yahoo.com
Eupraxia Pharmaceuticals Q4 Loss Widens
13-03-2026
yahoo.com
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
13-03-2026
yahoo.com
Eupraxia Pharmaceuticals Closes US$63.2M Public Offering Including Full Exercise of Underwriter Option
20-02-2026
yahoo.com
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
20-02-2026
yahoo.com
What is the current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?
The current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is $7.02.
EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is $-0.18.
EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is -2.5%.
What is the most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?
The most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?
The most recent sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is .
SEC-8K** Filing Available For EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.